PAIN
Volume 145, Issue 1 , Pages 8-9 , September 2009

Alpha-2-delta ligands in fibromyalgia: Is the glass half empty or full?

Received 5 June 2009 ,Accepted 5 June 2009.

References 

  1. Geisser ME, Strader DC, Petzke F, Gracely RH, Clauw DJ, Williams DA. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics. 2008;49:235–242
  2. Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH, et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum. 2008;58:903–907
  3. Häuser W, Bernardy K, Üçeyler N, Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin – A meta-analysis of randomized controlled trials. Pain. 2009;145:69–81
  4. Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K, et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain. 2007;8:737–745
  5. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis. 2004;63:901–907

PII: S0304-3959(09)00334-0

doi: 10.1016/j.pain.2009.06.015

PAIN
Volume 145, Issue 1 , Pages 8-9 , September 2009

Article Tools